amitriptyline metabolite (+/-)-
amitriptyline metabolite (+/-)- structure
|
Common Name | amitriptyline metabolite (+/-)- | ||
|---|---|---|---|---|
| CAS Number | 64520-05-4 | Molecular Weight | 293.40300 | |
| Density | 1.151g/cm3 | Boiling Point | 453.3ºC at 760mmHg | |
| Molecular Formula | C20H23NO | Melting Point | 97-99 °C | |
| MSDS | USA | Flash Point | 225.4ºC | |
| Name | (11E)-11-[3-(dimethylamino)propylidene]-5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-5-ol |
|---|---|
| Synonym | More Synonyms |
| Density | 1.151g/cm3 |
|---|---|
| Boiling Point | 453.3ºC at 760mmHg |
| Melting Point | 97-99 °C |
| Molecular Formula | C20H23NO |
| Molecular Weight | 293.40300 |
| Flash Point | 225.4ºC |
| Exact Mass | 293.17800 |
| PSA | 23.47000 |
| LogP | 3.65950 |
| Appearance of Characters | solid | white |
| Index of Refraction | 1.651 |
| Water Solubility | 0.1 M HCl: soluble |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Safety Phrases | 22-24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
~%
amitriptyline m... CAS#:64520-05-4 |
| Literature: Lassen; Perregaard 1983 , vol. 37, # 4 B p. 335 - 340 |
|
~%
amitriptyline m... CAS#:64520-05-4 |
| Literature: Lassen; Perregaard 1983 , vol. 37, # 4 B p. 335 - 340 |
|
~%
amitriptyline m... CAS#:64520-05-4 |
| Literature: Lassen; Perregaard 1983 , vol. 37, # 4 B p. 335 - 340 |
|
~%
amitriptyline m... CAS#:64520-05-4 |
| Literature: Lassen; Perregaard 1983 , vol. 37, # 4 B p. 335 - 340 |
|
~%
amitriptyline m... CAS#:64520-05-4 |
| Literature: Olesen, Ole V.; Linnet, Kristian Pharmacology, 1997 , vol. 55, # 5 p. 235 - 243 |
|
~%
amitriptyline m... CAS#:64520-05-4 |
| Literature: Masubuchi, Yasuhiro; Iwasa, Takashi; Fujita, Shoichi; Suzuki, Tokuji; Horie, Toshiharu; Narimatsu, Shizuo Journal of Pharmacy and Pharmacology, 1996 , vol. 48, # 9 p. 925 - 929 |
![N,Ndimethyl-3-(10,11-dihydro-10-oxo-5H-dibenzo[a,d]cycloheptene)-Δ5,γ-propylamine structure](https://image.chemsrc.com/caspic/417/37439-94-4.png)
![N,N-dimethyl-3-(10-(piperidin-1-yl)-5H-dibenzo[a,d][7]annulen-5-ylidene)propan-1-amine structure](https://image.chemsrc.com/caspic/456/88086-81-1.png)
![10-Bromo-5-(3-dimethylaminopropyl)-5-hydroxy-5H-dibenzo[a,d]cycloheptene structure](https://image.chemsrc.com/caspic/166/1562-53-4.png)
![3-(10-bromo-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine structure](https://image.chemsrc.com/caspic/335/2099-60-7.png)
|
Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes.
Clin. Pharmacol. Ther. 52(4) , 350-8, (1992) In 26 hospitalized patients with depression, a combined pharmacogenetic test with dextromethorphan, a substrate of cytochrome P450IID6, and mephenytoin, the S-form of which is hydroxylated by a P450II... |
|
|
Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes.
Drug Metab. Dispos. 9(6) , 565-8, (1981) The rates of demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline by microsomes from adult human livers were determined by use of mass-fragmentographic or liqui... |
|
|
CYP2D6 and CYP2C19 genotypes and amitriptyline metabolite ratios in a series of medicolegal autopsies.
Forensic Sci. Int. 158(2-3) , 177-83, (2006) In a series of 202 postmortem toxicology cases, the CYP2D6 and CYP2C19 genes were genotyped, and the concentrations of amitriptyline (AT) and six metabolites were analyzed. The polymorphic CYP2D6 and ... |
| 5H-Dibenzo(a,d)cyclohepten-10-ol,5-(3-(dimethylamino)propylidene)-10,11-dihydro-,(E) |
| ( inverted exclamation markA)-(E)-5-[3-(Dimethylamino)propylidene]-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-10-ol |
| Amitriptyline metabolite,( inverted exclamation markA)-E-10-hydroxylated |